161841
An assessment of cumulative exposure to lead and mercury in subsets of the US population
Monday, November 5, 2007: 5:15 PM
Daniel A. Axelrad
,
Office of Policy, U.S. EPA, Washington, DC
Tracey J. Woodruff, PhD, MPH
,
Program on Reproductive Health and the Environment, University of California, San Francisco, Oakland, CA
The metals lead and mercury are
known to independently exert neurotoxic effects in children following pre- and
postnatal exposures. Exposures to lead or mercury in US populations have been
largely characterized for each individual metal, and have also been shown to be
disproportionately distributed across race/ethnicity and socioeconomic groups. However,
not much is known about concurrent or cumulative exposure to both metals in the
US population. Generally, emerging research suggests that differences in exposure
to multiple pollutants exist in the US population, and these differences may
depend on socioeconomics and race/ethnicity. In this study, we assessed the
distribution of combined body burdens of lead and total mercury (as a measure
of exposure) in the US population using data from the 2001-2002 and 2003-2004
NHANES surveys. This analysis focused on children aged 1-5 because the
association between exposure and neurotoxicity is strongest for this age group
and also for data availability reasons, and women of child-bearing age (16-49)
because of pre-natal exposures. For both study populations, we identified NHANES
participants at or exceeding the 75th or 90th percentiles
for both metals in blood. These individuals were subsequently characterized by
race/ethnicity and income using descriptive data analysis methods. This
analysis is intended to serve as a case study on potential approaches for
estimating cumulative body burdens. Future analysis will include cadmium, the
third metal for which NHANES data is available.
Learning Objectives: 1.Participants should be able to describe differences in concurrent exposure to lead and mercury in children aged 1-5 and females aged 16-49 in the US population by socioeconomic status and race/ethnicity.
2.Participants should be able to articulate the methods used in the analysis.
Presenting author's disclosure statement:Any relevant financial relationships? No Any institutionally-contracted trials related to this submission?
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines,
and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed
in my presentation.
|